About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
BMY - Bristol-Myers Squibb...| Previous Close | $66.08 | Open | |
| Volume | 105 | Market Cap | 146.233B |
| Yield | 2.84 % | Last Dividend | $1.86 |
| Latest Upgrades and Downgrades: Bristol-... | 04/16/21 |
| TheStreet's weekly guide to upgrades, downgrades and price-target changes includes Bristol-Myers Squibb, GameStop and Disney. | |
| Bristol-Myers Gastric-Cancer Treatment C... | 04/16/21 |
| Bristol-Myers Squibb's Opdivo with chemotherapy was cleared by the FDA to treat patients with advanced gastric cancer. | |
| The Daily Biotech Pulse: Merck Shelves 2... | 04/15/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10... | |
| Goldman Sachs names 40 stocks to buy bef... | 04/11/21 |
| Summary List Placement Markets saw a strong start to the second quarter. The S&P 500 rose to a record high on April 1 and surpassed 4,000 points for t... | |
| Bristol-Myers' Opdivo-Chemo Combo Associ... | 04/08/21 |
| Bristol-Myers Squibb Co (NYSE: BMY ) has announced positive topline results from Phase 3 CheckMate 648 trial evaluating Opdivo (nivolumab) plus chemot... | |
| PsiOxus Therapeutics-Bristol Myers Expan... | 04/07/21 |
| PsiOxus Therapeutics Ltd has updated the agreement to advance its clinical collaboration with Bristol-Myers Squibb Co (NYSE: BMY ) to evaluate PsiOxus... | |
| Novel Cancer Therapy Phase 3 Trial Expec... | 04/06/21 |
| The following article is sponsored by Actinium Pharmaceuticals, Inc. The information contained in this article in no way represents investment advice ... | |
| Bristol Myers In Over $1B Tax Brawl Afte... | 04/01/21 |
| An accidental disclosure last spring at the I.R.S has reportedly exposed a $1 billion tax fight with Bristol-Myers Squibb Co (NYSE: BMY ). The agency ... | |
| An Accidental Disclosure Exposes a $1 Bi... | 04/01/21 |
| The I.R.S. believes the American drugmaker used an abusive offshore scheme to avoid federal taxes. | |
| U.S. Food and Drug Administration Approv... | 03/26/21 |
| Abecma is a first-in-class BCMA-directed personalized immune cell therapy delivered as a one-time infusion for triple-class exposed patients with mult... | |
| FDA Accepts New Drug Application For Bri... | 03/22/21 |
| Bristol Myers Squibb, a biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA... | |
| Cancer Treatment Drugs Market to witness... | 03/19/21 |
| Global Cancer Treatment Drugs Market Synopsis: Cancer is a disease, which includes the irregular rise of cells that results in the formation of a tumo... | |
| U.S. Food and Drug Administration (FDA) ... | 03/19/21 |
| PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #FDA--U.S. FDA Accepts Bristol Myers Squibb???s Application for Mavacamten in Symptomatic Obstructive Hypert... | |
| Why Idera Pharmaceuticals Shares Dropped... | 03/18/21 |
| Shares of Idera Pharmaceuticals Inc . (NASDAQ: IDRA ) plunged more than 62% in the extended session Thursday after the biopharmaceutical company said ... | |
| Novartis, Bristol Myers join $72M fundin... | 03/18/21 |
| Aktis Oncology is developing cancer radiation treatments intended to more precise and potent compared to other radiotherapies. The startup is now out ... | |
| Are radiopharmaceuticals ready for the m... | 03/18/21 |
| Brian Goodman, Patrick Baeuerle and Todd Foley weren???t exactly looking to start a radiopharmaceuticals company. Rather, the team at MPM Capital ??? ... | |
| 3 Biotech Stocks That Could Double In 12... | 03/17/21 |
| Biotech stocks are risky investment bets that can swing an investor's fortunes in a big way. An investment decision backed by careful scrutiny and ana... | |
| Polycystic Ovarian Syndrome Treatment Ma... | 03/16/21 |
| Surge in incidence of PCOS, rise in number of pipeline drugs, and increase in healthcare expenditure worldwide drive the growth of the global polycyst... | |
| Global Leukemia Therapeutics Market by M... | 03/15/21 |
| Leukemia Therapeutics Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regio... | |
| Barron's Latest Picks And Pans: Apple, C... | 03/13/21 |
| This weekend's Barron's cover story discusses how the U.S. economy could soar as the pandemic fades. Other featured articles discuss why big pharmaceu... | |
| Global Nanomaterials in Personalized Med... | 03/12/21 |
| DUBLIN--(BUSINESS WIRE)--The "Nanomaterials in Personalized Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering. The ... | |
| AVEO Oncology Announces Collaboration wi... | 03/12/21 |
| BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that it has entered into a clinical trial collaboration and supply agreement wit... | |
| Ischemic Heart Disease Drugs Market 2028... | 03/10/21 |
| Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ???Ischemic Heart Disease Drugs Market: Global Opportunity Analysis and... | |
| The Zacks Analyst Blog Highlights: Maste... | 03/08/21 |
| The Zacks Analyst Blog Highlights: Mastercard, NVIDIA, Costco, Disney and Bristol-Myers Squibb | |
| Roche joins the FDA accelerated approval... | 03/08/21 |
| After similar moves by fellow immuno-oncology players Bristol Myers Squibb, AstraZeneca and Merck & Co., Roche has pulled a Tecentriq bladder cancer i... | |
| SMALL CAP SHARE IDEAS: Bloomsbury Publis... | 03/08/21 |
| In commercial terms, there have been undoubted winners and losers from the coronavirus pandemic and Bloomsbury Publishing looks like a winner. | |
| Peripheral Neuropathy Treatment Market S... | 03/07/21 |
| The New Report ???Peripheral Neuropathy Treatment Market??? published by Coherent Market Insights, covers the market landscape and its growth prospect... | |
| Cancer Immunotherapy Market Analysis Foc... | 03/05/21 |
| The "Global Cancer Immunotherapy Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a particular focus on... | |
| Pharmacovigilance Market Business Opport... | 03/05/21 |
| Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects... | |
| Bone Cancer Market With Key Players like... | 03/03/21 |
| Bone cancer is diagnosed when there is abnormal cell growth in the bone and it tends to destroy bone tissue. It is a rare type of cancer in adults how... | |
| Buy rating | 04/13/21 |
| Truist Securities upgrades from Hold to Buy rating and raises Price Target from $66.00 to $74.00 | |
| Date | 2021-02-04 (BMO) | Est. (EPS/Rev.) | $1.41/ 10.73B |
| Actual (EPS/Rev.) | $1.46/ $11.07 B | EPS (TTM) | 0.81 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Options Eagle | George | 78.00 % | Follow |
| Option Superstars | James Catzen | 72.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| optionguy | Vipul Champaneri | 63.00 % | Follow |
| Options Marc | Marc M | 55.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
